Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Paragon Care Limited ( (AU:PGC) ) has issued an update.
Paragon Care Limited, an Australian-listed healthcare provider, offers a broad range of medical equipment, devices, consumables, pharmaceuticals, complementary medicines, and nutritional supplies. The company also produces blood bank diagnostic reagents, with a geographic focus spanning Australia, New Zealand, and Asia.
Paragon Care will release its half-year FY26 financial results and an accompanying investor presentation to the ASX on 25 February 2026. Following the release, CEO Carmen Riley and CFO Brendon Pentland will host a webcast and conference call with a Q&A session, underscoring the company’s engagement with investors and transparency around its financial performance.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-listed healthcare company that supplies medical equipment, devices, consumables, pharmaceuticals, complementary medicines, and nutritional products. It also manufactures blood bank diagnostic reagents, serving healthcare markets across Australia, New Zealand, and Asia.
Average Trading Volume: 1,116,734
Technical Sentiment Signal: Sell
Current Market Cap: A$339.3M
For detailed information about PGC stock, go to TipRanks’ Stock Analysis page.